Proassurance (PRA) Cash & Equivalents (2009 - 2026)

Proassurance (PRA) has 18 years of Cash & Equivalents data on file, last reported at $14.1 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $14.1 million, down 67.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 million (down 67.72% YoY), and the FY2025 annual result was $36.5 million, down 33.5% from the prior year.
• Cash & Equivalents retreated to $14.1 million in Q1 2026 per PRA's latest filing, from $36.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $72.1 million in Q1 2022 and troughed at $14.1 million in Q1 2026.
• A 5-year average of $47.1 million and a median of $45.3 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 79.61% in 2022, then jumped 119.96% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $30.0 million in 2022, then jumped by 119.96% to $65.9 million in 2023, then declined by 16.72% to $54.9 million in 2024, then sank by 33.5% to $36.5 million in 2025, then sank by 61.49% to $14.1 million in 2026.
• Business Quant data shows PRA's Cash & Equivalents at $14.1 million in Q1 2026, $36.5 million in Q4 2025, and $54.5 million in Q3 2025.